Company Filing History:
Years Active: 2014
Title: Innovator Spotlight: Anna Bafico and Her Contributions to Cancer Treatment
Introduction: Anna Bafico is a distinguished inventor based in New York, NY, known for her significant contributions to the field of cancer research. With her innovative approach to understanding Wnt signaling pathways, Bafico has paved the way for potential therapeutic interventions in cancer treatment.
Latest Patents: Anna Bafico holds a patent titled "Compositions and methods for altering Wnt autocrine signaling." This patent focuses on compounds and methods designed to treat cancers characterized by activated autocrine Wnt canonical signaling pathways. It presents a novel method for inhibiting the growth of tumor cells and sensitizing cancer cells to treatment by using compounds that alter Wnt signaling. These compounds may include a Wnt antagonist, a Wnt receptor antagonist, or a combination of both.
Career Highlights: Bafico is currently affiliated with the Icahn School of Medicine at Mount Sinai, where she engages in groundbreaking research aimed at tackling cancer. She is recognized for her innovative contributions and the potential impact of her work on cancer therapies.
Collaborations: Throughout her career, Anna has collaborated with esteemed colleagues, including Stuart A. Aaronson. These partnerships have strengthened her research efforts and broadened the application of her inventions in the medical field.
Conclusion: Anna Bafico’s inventive spirit and dedication to cancer research exemplify the essence of innovation in medicine. Her patented methods provide hope for better cancer treatment options, highlighting the importance of ongoing research and the role of inventors in advancing healthcare solutions.